{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T10:22:04Z","timestamp":1768040524328,"version":"3.49.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:p>In Europe as a whole, survival from skin malignant melanoma (SMM) has increased constantly since the 1980s. The aim of the SUDCAN collaborative study was to compare the trends in the 5-year net survival from SMM and in related excess mortality rate between six European Latin countries (Belgium, France, Italy, Portugal, Spain, and Switzerland). The data were extracted from the EUROCARE-5 database (end of follow-up: 01 January 2009). First, the net survival was studied over the 2000\u20132004 period using the Pohar-Perme estimator. For trend analyses, the study period was specific to each country. The results are reported from 1992 to 2004 in France, Italy, Spain, and Switzerland and from 2000 to 2004 in Belgium and Portugal. The analyses were carried out using a flexible excess rate modeling. Over the 2000\u20132004 period, the 5-year net survival from SMM ranged from 79 (Portugal) to 90% (Switzerland). In all countries, net survival was higher in women versus men and in young versus old age groups. From 1992 to 2004, the 5-year net survival increased the most in the countries with the lowest survivals in 1992 (+9% in Italy and Spain vs. +2% in Switzerland or +4% in France). The differences between countries decreased between 1992 and 2004. Although survival increased to a lower or higher extent in all countries during the period studied, significant differences in net survival from SMM persisted among the six countries studied. Health policies should mainly enhance early diagnosis by increasing public awareness and with screening campaigns. Furthermore, new immunotherapies, which will be approved soon hopefully, should also be used to improve the outcomes of SMM treatment.<\/jats:p>","DOI":"10.1097\/cej.0000000000000306","type":"journal-article","created":{"date-parts":[[2016,12,21]],"date-time":"2016-12-21T18:21:56Z","timestamp":1482344516000},"page":"S77-S84","source":"Crossref","is-referenced-by-count":17,"title":["Trends in net survival from skin malignant melanoma in six European Latin countries: results from the SUDCAN population-based study"],"prefix":"10.1097","volume":"26","author":[{"given":"Jaume","family":"Galceran","sequence":"first","affiliation":[{"name":"Tarragona Cancer Registry, Foundation Society for Cancer Research and Prevention, IISPV, Rovira i Virgili University, Thematic Network of Cooperative Research in Cancer"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zo\u00e9","family":"Uhry","sequence":"additional","affiliation":[{"name":"Department of Non-communicable Diseases and Injuries, French Institute for Public Health Surveillance (Invs), Saint-Maurice"},{"name":"Department of Biostatistics, University Hospital of Lyon"},{"name":"University of Lyon, Lyon"},{"name":"University of Lyon 1"},{"name":"CNRS, UMR 5558, Biometry and Evolutionary Biology Laboratory (LBBE), BioMaths-Health Department, Villeurbanne, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Marcos-Gragera","sequence":"additional","affiliation":[{"name":"Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology, Girona Biomedical Research Institute (IdiBGi), Girona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Borr\u00e0s","sequence":"additional","affiliation":[{"name":"Oncology Institute of Southern Catalonia, Saint Joan University Hospital, IISPV, Rovira i Virgili University, Thematic Network of Cooperative Research in Cancer, Reus"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230901","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3322\/canjclin.54.3.131","article-title":"An evidence-based staging system for cutaneous melanoma","volume":"54","author":"Balch","year":"2004","journal-title":"CA Cancer J Clin"},{"issue":"Suppl 1","key":"R2-20230901","first-page":"S3","article-title":"Trends in net survival from 15 cancers in six European Latin countries: the SUDCAN population-based study material","volume":"25","author":"Crocetti","year":"2016","journal-title":"Eur J Cancer Prev"},{"key":"R3-20230901","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1470-2045(13)70546-1","article-title":"Cancer survival in Europe 1999\u20132007 by country and age: results of EUROCARE-5 \u2013 a population-based study","volume":"15","author":"De Angelis","year":"2014","journal-title":"Lancet Oncol"},{"issue":"Suppl 7","key":"R4-20230901","doi-asserted-by":"crossref","first-page":"vii86","DOI":"10.1093\/annonc\/mds229","article-title":"Cutaneous melanoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"23","author":"Dummer","year":"2012","journal-title":"Ann Oncol"},{"key":"R5-20230901","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1200\/JCO.2013.52.7564","article-title":"Later stage at diagnosis and worse survival in cutaneous malignant melanoma among men living alone: a nationwide population-based study from Sweden","volume":"32","author":"Eriksson","year":"2014","journal-title":"J Clin Oncol"},{"key":"R9-20230901","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/jid.2010.354","article-title":"Gender differences in melanoma survival: female patients have a decreased risk of metastasis","volume":"131","author":"Joosse","year":"2011","journal-title":"J Invest Dermatol"},{"key":"R10-20230901","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1468-3083.2010.03602.x","article-title":"Rising trends in incidence of cutaneous malignant melanoma and their future projections in Catalonia, Spain: increasing impact or future epidemic?","volume":"24","author":"Marcos-Gragera","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R11-20230901","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1541-0420.2011.01640.x","article-title":"On estimation in relative survival","volume":"68","author":"Perme","year":"2012","journal-title":"Biometrics"},{"key":"R12-20230901","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/S0959-8049(01)00206-4","article-title":"Cancer survival increases in Europe, but international differences remain wide","volume":"37","author":"Sant","year":"2001","journal-title":"Eur J Cancer"},{"issue":"Suppl 5","key":"R13-20230901","doi-asserted-by":"crossref","first-page":"v61","DOI":"10.1093\/annonc\/mdg754","article-title":"EUROCARE-3: survival of cancer patients diagnosed 1990\u20131994 \u2013 results and commentary","volume":"14","author":"Sant","year":"2003","journal-title":"Ann Oncol"},{"key":"R14-20230901","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.ejca.2008.11.018","article-title":"EUROCARE-4. Survival of cancer patients diagnosed in 1995\u20131999. Results and commentary","volume":"45","author":"Sant","year":"2009","journal-title":"Eur J Cancer"},{"issue":"Suppl 1","key":"R16-20230901","first-page":"S9","article-title":"New insights into survival trend analyses in cancer population-based studies: the SUDCAN methodology","volume":"25","author":"Uhry","year":"2016","journal-title":"Eur J Cancer Prev"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008469-201701001-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T10:26:45Z","timestamp":1718965605000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008469-201701001-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":12,"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000000306","relation":{},"ISSN":["0959-8278"],"issn-type":[{"value":"0959-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}